LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Regulated Cell Death in Neurodegenerative Diseases
- 1st Edition - May 1, 2025
- Editors: Heba Mohamed Mansour, Aiman Saad El-Khatib
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 2 8 5 2 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 2 8 5 3 - 4
Regulated Cell Death in Neurodegenerative Diseases provides a complete overview of the molecular mechanisms of regulated cell death in neurodegenerative disorders, including apopto… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteRegulated Cell Death in Neurodegenerative Diseases provides a complete overview of the molecular mechanisms of regulated cell death in neurodegenerative disorders, including apoptosis, necroptosis, ferroptosis, pyroptosis, autophagy-mediated cell death, and parthanatos. This book provides researchers and clinicians with a detailed understanding of the mechanisms of regulated cell death, highlighting potential targets for developing new therapeutic approaches.
- Provides detailed analysis of the mechanisms and significance of different types of regulated cell death in neurodegenerative diseases
- Explores potential targets for regulating cell death in neurodegenerative diseases
- Reviews therapeutic approaches targeting regulated cell death including anti-apoptotic drugs, necroptosis inhibitors, and more
Researchers in neuroscience, neurodegeneration. Clinicians who are interested in the underlying mechanisms of neurodegenerative disorders, specifically the role of regulated cell death in neurodegenerative conditions
1. Regulated Cell Death (RCD): Discovery, Features, and Implications for Neurodegenerative Diseases
2. Crosstalk Between Different Regulated Cell Death Mechanisms in Neurodegenerative Diseases
3. Apoptosis in Neurodegenerative Disorders
4. Necroptosis in Neurodegenerative Disorders
5. Ferroptosis in Neurodegenerative Disorders
6. Pyroptosis in Neurodegenerative Disorders
7. Autophagy-Mediated Cell Death: Mechanisms and Implications in Neurodegenerative Disorders
8. Parthanatos in Neurodegenerative Diseases
9. Potential Targets for Regulating Cell Death in Neurodegenerative Disorders
10. Chaperones Control of Regulated Cell Death
11. Kinases Control of Regulated Cell Death in Neurodegenerative Disorders
12. Regulated Cell Death and Inflammaging in Neurodegenerative Disorders
13. Role of Oxidative Stress and Mitochondrial Dysfunction in Regulating RCD in Neurodegenerative Disorders
14. Therapeutic Approaches Targeting Regulated Cell Death in Neurodegenerative Diseases
2. Crosstalk Between Different Regulated Cell Death Mechanisms in Neurodegenerative Diseases
3. Apoptosis in Neurodegenerative Disorders
4. Necroptosis in Neurodegenerative Disorders
5. Ferroptosis in Neurodegenerative Disorders
6. Pyroptosis in Neurodegenerative Disorders
7. Autophagy-Mediated Cell Death: Mechanisms and Implications in Neurodegenerative Disorders
8. Parthanatos in Neurodegenerative Diseases
9. Potential Targets for Regulating Cell Death in Neurodegenerative Disorders
10. Chaperones Control of Regulated Cell Death
11. Kinases Control of Regulated Cell Death in Neurodegenerative Disorders
12. Regulated Cell Death and Inflammaging in Neurodegenerative Disorders
13. Role of Oxidative Stress and Mitochondrial Dysfunction in Regulating RCD in Neurodegenerative Disorders
14. Therapeutic Approaches Targeting Regulated Cell Death in Neurodegenerative Diseases
- No. of pages: 600
- Language: English
- Edition: 1
- Published: May 1, 2025
- Imprint: Academic Press
- Paperback ISBN: 9780443328527
- eBook ISBN: 9780443328534
HM
Heba Mohamed Mansour
Heba M. Mansour works at Central Administration of Biologicals, Innovative Products, and Clinical Studies (Bio-Inn), Egyptian Drug Authority (EDA). Heba is also pursuing her Ph.D. in pharmacology and toxicology at Faculty of Pharmacy, Cairo University. Her research interests lie in the potential repositioning of anti-cancer drugs especially kinase inhibitors in neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. She has authored several articles, including research papers in prestigious international journals, book chapters, and review articles.
Affiliations and expertise
Central Administration of Biological, Innovative Products, and Clinical Studies (Bio-INN), Egyptian Drug Authority (EDA), EgyptAE
Aiman Saad El-Khatib
Aiman Saad El-Khatib is currently the Vice President of the Egyptian Drug Authority. He is a Professor of Pharmacology and Toxicology in the Faculty of Pharmacy, Cairo University. He held several leadership positions in Cairo University including Vice President for Graduate Studies and Research Affairs, Dean of Faculty of Pharmacy, Vice Dean for Education and Students Affairs as well as Vice Dean for Community Service and Environment Development. Additionally, he held the post of Assistant Minister of Health and Population for Pharmaceutical Affairs. His primary research area of interest is investigation of the pharmacological properties of various drugs, including natural products on the gastrointestinal tract, cardiovascular and central nervous systems.
Affiliations and expertise
Egyptian Drug Authority (EDA) and Professor of Pharmacology and Toxicology in the Faculty of Pharmacy, Cairo University, Egypt